Bevacizumab, Oxaliplatin, and Docetaxel in Treating Patients With Locally Advanced Unresectable or Metastatic Stomach or Gastroesophageal Junction Cancer
Clinical trial NCT00217581 · COMPLETED
Trial details
- NCT number
- NCT00217581
- Sponsor
- Barbara Ann Karmanos Cancer Institute
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2004-10-01
- Primary completion
- 2012-11-01
- Enrollment
- 39
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.